Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common stock, par value $0.001 per share
-
Shares outstanding
-
29,061,083
-
Total 13F shares
-
31,022,012
-
Share change
-
+2,429,801
-
Total reported value
-
$6,309,755,960
-
Put/Call ratio
-
144%
-
Price per share
-
$203.43
-
Number of holders
-
344
-
Value change
-
+$504,375,008
-
Number of buys
-
171
-
Number of sells
-
195
Institutional Holders of Inspire Medical Systems, Inc. - Common stock, par value $0.001 per share (INSP) as of Q4 2023
As of 31 Dec 2023,
Inspire Medical Systems, Inc. - Common stock, par value $0.001 per share (INSP) was held by
344 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
31,022,012 shares.
The largest 10 holders included
FMR LLC, VANGUARD GROUP INC, BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, BAILLIE GIFFORD & CO, WASATCH ADVISORS LP, FARALLON CAPITAL MANAGEMENT LLC, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, FRONTIER CAPITAL MANAGEMENT CO LLC, and Champlain Investment Partners, LLC.
This page lists
344
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.